Xenon Pharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Xenon Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Xenon Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $8.57M, a 12.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $8.57M -$1.23M -12.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $8.88M -$1.21M -12% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $9.19M -$1.21M -11.7% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $9.5M +$1.94M +25.6% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $9.8M +$2.07M +26.8% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $10.1M +$2.2M +27.8% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $10.4M +$2.35M +29.2% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $7.56M +$4.59M +155% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $7.73M +$4.64M +150% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $7.9M +$4.69M +146% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $8.06M +$4.73M +142% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $2.97M +$2.08M +235% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.09M +$2.06M +200% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $3.21M +$2.37M +285% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $3.33M +$2.39M +256% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $886K -$150K -14.5% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.03M -$106K -9.34% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $832K -$401K -32.5% Mar 31, 2020 10-Q/A 2020-05-26
Q4 2019 $933K Dec 31, 2019 10-K 2021-03-01
Q3 2019 $1.04M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $1.14M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $1.23M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.